Ondansetron 4 MG Disintegrating Tablet
INDICATIONS AND USAGE prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy, including cisplatin ≥ 50 mg/m 2 . prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy. prevention of nausea and vomiting associated with radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen. prevention of postoperative nausea and/or vomiting. As with other antiemetics, routine prophylaxis is not recommended for patients in whom there is little expectation that nausea and/or vomiting will occur postoperatively. In patients where nausea and/or vomiting must be avoided postoperatively, ondansetron orally disintegrating tablets are recommended even where the incidence of postoperative nausea and/or vomiting is low.
sun pharmaceutical industries limited
OVAL WHITE 240
Related Pills
ondansetron 8 MG Disintegrating Oral Tablet
Sun Pharmaceutical Industries Limited
Tecfidera 30Day Starter Pack
Biogen Idec Inc.
Lorazepam 0.5 mg
Watson Laboratories, Inc.
Lorazepam 0.5 MG Oral Tablet
Aphena Pharma Solutions - Tennessee, LLC
Lorazepam 0.5 MG Oral Tablet
Aphena Pharma Solutions - Tennessee, LLC
Lorazepam 0.5 mg
Watson Laboratories, Inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED Ondansetron orally disintegrating tablets, 4 mg (as 4 mg ondansetron base) are white to off white, oval, uncoated tablets debossed with “240” on one side, plain on the other side. Bottle pack of 30 tablets with Child Resistant Cap (NDC 62756-240-83) Unit dose packs of 30 tablets (NDC 62756-240-64) Ondansetron orally disintegrating tablets, 8 mg (as 8 mg ondansetron base) are white to off white, oval, uncoated tablets debossed with “241” on one side, plain on the other side. Bottle pack of 30 tablets with Child Resistant Cap (NDC 62756-356-83) Unit dose packs of 30 tablets (NDC 62756-356-64) Unit dose packs of 10 tablets (NDC 62756-356-66) Store between 20° to 25°C (68° to 77°F). [see USP Controlled Room Temperature]
More pills like OVAL 240